| Literature DB >> 35761921 |
Mikael Mir1, Ibtisam Rauf2, Sarah Goksoy3, Anwar Khedr4, Abbas B Jama4, Hisham Mushtaq4, Nitesh K Jain4, Syed Anjum Khan4, Salim Surani5,6,7,8,9, Thoyaja Koritala10.
Abstract
The US Food and Drug Administration (FDA) recently approved the marketing of an electronic cigarette (e-cig) brand called Vuse (RJ Reynolds Vapor Company, US) to help aid in smoking cessation for adult smokers. It was believed that the consumption of traditional cigarettes and their harmful effects would be reduced given the availability of newer e-cigarettes. However, adolescent use of tobacco and nicotine products rather increased with the availability of the same e-cigarettes, and the FDA-approved market boom only worsened this problem. Although the FDA underlines the importance of marketing e-cigarettes as a possible solution for adult traditional smoking, its consequences on adolescents' health raise many concerns, which we narrated in this review article.Entities:
Keywords: e-cigarettes; electronic cigarettes; smoking cessation; vaping; vuse
Year: 2022 PMID: 35761921 PMCID: PMC9232181 DOI: 10.7759/cureus.25330
Source DB: PubMed Journal: Cureus ISSN: 2168-8184